Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

Fulvestrant 82Letrozole 75Paclitaxel 71pembrolizumab 67Specimen Handling 63Trastuzumab 61Carboplatin 56Magnetic Resonance Spectroscopy 50ribociclib 47Capecitabine 47Anastrozole 46pertuzumab 45palbociclib 44exemestane 38Tamoxifen 38Cyclophosphamide 38abemaciclib 37Biopsy 36trastuzumab deruxtecan 30Docetaxel 29Taxes 27Gemcitabine 25Radiotherapy 24Surveys and Questionnaires 23130-nm albumin-bound paclitaxel 23Blood Specimen Collection 22Standard of Care 21sacituzumab govitecan 20olaparib 20eribulin 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
68Ga-FAPI × Breast × 90 days × Clear all
NCT07553741 2026-04-28

Application and Comparison of [68Ga]Ga-FAPI-04 PET, [18F]FDG PET, and Contrast-Enhanced MRI in Predicting Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase NA Completed
27 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡